receives approval for extra AI CT, x-ray indications

By staff writers

April 14, 2023 -- Australian-based artificial intelligence (AI) software developer has secured clearances from the U.S. Food and Drug Administration (FDA) that cover additional indications for use of its CT and x-ray triage and notification software.

Annalise Triage uses deep learning to identify the suspected presence of time-sensitive pathologies and flag priority cases within the radiology worklist, assisting the care team in treating patients with the most critical conditions first.

New clearances for the company's Triage CT Brain algorithm include the following:

  • Acute subdural/epidural hematoma
  • Acute subarachnoid hemorrhage
  • Intra-axial hemorrhage
  • Intraventricular hemorrhage

In addition, clearances for the company's Triage Chest X-ray algorithm now include the following:

  • Pneumothorax
  • Tension pneumothorax
  • Pleural effusion
  • Pneumoperitoneum
  • Vertebral compression fracture

The latest FDA clearances will allow the company to expand into the U.S. market and bring the total number of U.S.-available findings for its triage and notification products to nine, representatives said.

Copyright © 2023

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking